Literature DB >> 27539340

[The coverage of hepatitis A vaccine among 2-29 year olds and the reporting incidence of hepatitis A in China, 2014].

F Z Wang1, H Zheng1, J H Liu2, X J Sun1, N Miao1, L P Shen3, G M Zhang1, F Q Cui4.   

Abstract

OBJECTIVE: To evaluate the hepatitis A vaccine coverage among 2-29 year olds and the reported incidence rates of hepatitis A, in China.
METHODS: Based on data from the national sero-survey on hepatitis B in 2014, information on hepatitis A vaccine immunization was collected and the coverage of hepatitis A vaccine was analyzed with SAS software (Version 9.4). Incidence data on hepatitis A was also collected from the National Notifiable Disease Reporting System between 2004 and 2014, and analyzed using the micro-software Excel 2007.
RESULTS: Totally, data involving 29 058 people aged 2-29 years were available for analysis and the overall hepatitis A vaccine coverage was 44.6%. The younger the age, the higher the coverage appeared. Among the 2-6 year and the 7-14 year olds, rates of hepatitis A vaccine coverage were 91.2% and 76.0% respectively. From 2004 to 2014, the incidence rates of hepatitis A in the whole population were declining, annually. The incidence rates showed continuously declining as 82.5%, 90.6%, 72.1% among children at the age groups of 2-6 years, 7-14 years and in the whole population, from 2007 to 2013.
CONCLUSION: After the inclusion of hepatitis A vaccine into the Expanded Programe on Immunization (EPI), the coverage of hepatitis A vaccine among the 2-6 year olds increased to over 90%, with no obvious difference between the urban and rural areas. Incidence of hepatitis A in the 2-6 year olds showed a more rapid decline than that in the whole population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27539340     DOI: 10.3760/cma.j.issn.0254-6450.2016.08.009

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine.

Authors:  Zhilun Zhang; Xiangjun Zhu; Yuansheng Hu; Miao Liang; Jin Sun; Yufei Song; Qi Yang; Haiquan Ji; Gang Zeng; Lifei Song; Jiangting Chen
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

2.  Changes in the epidemiology of hepatitis A in three socio-economic regions of China, 1990-2017.

Authors:  Xiao-Jin Sun; Guo-Min Zhang; Rong-Jun Zhou; Hui Zheng; Ning Miao; Zun-Dong Yin; Fu-Zhen Wang
Journal:  Infect Dis Poverty       Date:  2019-10-03       Impact factor: 4.520

3.  Trend in the incidence of hepatitis A in mainland China from 2004 to 2017: a joinpoint regression analysis.

Authors:  Yuan-Sheng Li; Bei-Bei Zhang; Xi Zhang; Ya-Mei Luo; Jun-Hui Zhang; Song Fan; Li-Ping Fei; Chao Yang; Ning-Jun Ren; Xiang Li
Journal:  BMC Infect Dis       Date:  2022-08-01       Impact factor: 3.667

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.